Tekla Capital Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,836
| Closed | -$1.41M | – | 198 |
|
|
2019
Q2 | $1.41M | Buy |
+10,836
| New | +$1.41M | 0.06% | 149 |
|
|
2018
Q3 | – | Sell |
-4,688
| Closed | -$1.46M | – | 213 |
|
|
2018
Q2 | $1.46M | Sell |
4,688
-4,687
| -50% | -$1.46M | 0.06% | 149 |
|
|
2018
Q1 | $2.28M | Buy |
9,375
+975
| +12% | +$237K | 0.09% | 130 |
|
|
2017
Q4 | $2.54M | Buy |
+8,400
| New | +$2.54M | 0.1% | 118 |
|
|
2017
Q1 | – | Sell |
-3,742
| Closed | -$1.08M | – | 144 |
|
|
2016
Q4 | $1.08M | Sell |
3,742
-2,398
| -39% | -$692K | 0.05% | 127 |
|
|
2016
Q3 | $2.09M | Buy |
+6,140
| New | +$2.09M | 0.08% | 116 |
|
|
2015
Q3 | – | Sell |
-29,630
| Closed | -$11.6M | – | 141 |
|
|
2015
Q2 | $11.6M | Hold |
29,630
| – | – | 0.42% | 52 |
|
|
2015
Q1 | $8.96M | Buy |
+29,630
| New | +$8.96M | 0.36% | 62 |
|